Sale!

PLEKHG5 Gene Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PLEKHG5 Gene Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 Genetic Test is a specialized diagnostic examination designed to identify mutations in the PLEKHG5 gene, which are linked to the development of Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 (DSMA4). DSMA4 is a rare genetic disorder characterized by muscle weakness and atrophy, primarily affecting the distal muscles closest to the center of the body, such as those of the feet and hands. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics, offering a comprehensive range of genetic testing services. The cost of the test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of mutations in the PLEKHG5 gene. This genetic test is crucial for the accurate diagnosis of DSMA4, enabling affected individuals and their families to understand their condition better and make informed decisions regarding management and treatment options. It also provides valuable information for genetic counseling, especially for families with a history of the disorder or those planning to have children.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLEKHG5 Gene Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 Genetic Test

Test Details

The PLEKHG5 gene is associated with a specific type of spinal muscular atrophy called distal spinal muscular atrophy, autosomal recessive type 4 (DSMA4). This condition is characterized by muscle weakness and wasting, primarily affecting the muscles in the hands and feet.

NGS Technology

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the PLEKHG5 gene. It uses advanced sequencing technology to examine the DNA sequence of these genes and identify any genetic variants or mutations that may be present.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for PLEKHG5 Gene Spinal muscular atrophy distal, autosomal recessive type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLEKHG5 Gene Spinal muscular atrophy distal, autosomal recessive type 4.

Benefits of Test

By performing an NGS genetic test for the PLEKHG5 gene, healthcare professionals can determine if there are any disease-causing mutations or variants in this gene that may be contributing to the individual’s symptoms of DSMA4. This information can be helpful in confirming a diagnosis, providing prognostic information, and guiding treatment decisions.

Test Name PLEKHG5 Gene Spinal muscular atrophy distal autosomal recessive type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLEKHG5 Gene Spinal muscular atrophy distal, autosomal recessive type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLEKHG5 Gene Spinal muscular atrophy distal, autosomal recessive type 4
Test Details

The PLEKHG5 gene is associated with a specific type of spinal muscular atrophy called distal spinal muscular atrophy, autosomal recessive type 4 (DSMA4). This condition is characterized by muscle weakness and wasting, primarily affecting the muscles in the hands and feet.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the PLEKHG5 gene. It uses advanced sequencing technology to examine the DNA sequence of these genes and identify any genetic variants or mutations that may be present.

By performing an NGS genetic test for the PLEKHG5 gene, healthcare professionals can determine if there are any disease-causing mutations or variants in this gene that may be contributing to the individual’s symptoms of DSMA4. This information can be helpful in confirming a diagnosis, providing prognostic information, and guiding treatment decisions.